Keyword: Johnson & Johnson
News
03.04.2013
- Shares of Optimer Pharmaceuticals rose as much as 24% after a Bloomberg report said GlaxoSmithKline and Cubist Pharmaceuticals were among those interested in buying the antibiotic...
News
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
News
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
News
09.03.2013
- A Los Angeles jury ordered Johnson & Johnson's DePuy orthopedic unit to pay more than $8 million in damages in the first trial of nearly 11,000 lawsuits filed over the company's...
News
27.02.2013
- GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...
News
25.02.2013
- Investment firm Royalty Pharma has made a $6.6 billion bid approach to Elan, seeking to scupper the Irish drugmaker's plan to spend most of the proceeds from a major drug sale on...
News
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...
News
07.02.2013
- Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...
